Jon W. Osgood
Fondateur chez Cutlass Capital LLC
Profil
Mr. Jon W.
Osgood is Co-Founder & Managing Member at Cutlass Capital LLC since August 2001.
Prior to co-founding Cutlass Capital, Mr. Osgood was a Research Analyst at Deutsche Banc Alex.
Brown and its predecessors from 1983 to 2000.
He was Global Head of Health Care Research from 1984 until 2000, and headed one of the largest health care research departments on Wall Street with over 40 professionals worldwide.
His industry analytical responsibilities included every sector of health care, with special emphasis on medical technology and health care information systems.
Mr. Osgood was elected several times to the Institutional Investor All-America Research Team and was named a Wall Street Journal All-Star for his stock picking ability.
Mr. Osgood earned a BA (Magna Cum Laude and Phi Beta Kappa) from Dartmouth College and an MBA (Amos Tuck Scholar) from the Amos Tuck School of Business Administration at Dartmouth.
Postes actifs de Jon W. Osgood
| Sociétés | Poste | Début |
|---|---|---|
Cutlass Capital LLC
 Cutlass Capital LLC Investment ManagersFinance Cutlass Capital LLC (Cutlass Capital) is a venture capital firm founded in 2001 by Jon Osgood and David Hetz. The firm is headquartered in Boston. | Fondateur | 01/01/2001 |
Anciens postes connus de Jon W. Osgood
| Sociétés | Poste | Fin |
|---|---|---|
TranS1, Inc.
 TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | Directeur/Membre du Conseil | 03/06/2013 |
Cash Reserve Fund, Inc.
 Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Cash Reserve Fund, Inc. operates as an open-end investment fund trust. The fund offers prime, treasury and tax-free series. The fund was established in 1990 and is headquartered in New York, NY. | Corporate Officer/Principal | 31/12/1999 |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | Directeur/Membre du Conseil | - |
Hemosphere, Inc.
 Hemosphere, Inc. Medical SpecialtiesHealth Technology Hemosphere, Inc. operates as a medical device company. It engages in the development and commercialization of a vascular access device for treating hemodialysis patients with compromised vasculature. The company was founded in 1998 and is headquartered in Eden Prairie, MN. | Directeur/Membre du Conseil | - |
CardioKinetix, Inc.
 CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | - |
Formation de Jon W. Osgood
| Dartmouth College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cutlass Capital LLC
Cutlass Capital LLC Investment ManagersFinance Cutlass Capital LLC (Cutlass Capital) is a venture capital firm founded in 2001 by Jon Osgood and David Hetz. The firm is headquartered in Boston. | Finance |
GI Dynamics, Inc.
 GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
TranS1, Inc.
TranS1, Inc. Medical SpecialtiesHealth Technology TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC. | Health Technology |
Cash Reserve Fund, Inc.
Cash Reserve Fund, Inc. Investment Trusts/Mutual FundsMiscellaneous Cash Reserve Fund, Inc. operates as an open-end investment fund trust. The fund offers prime, treasury and tax-free series. The fund was established in 1990 and is headquartered in New York, NY. | Miscellaneous |
Xoft, Inc.
 Xoft, Inc. Data Processing ServicesTechnology Services Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA. | Technology Services |
CardioKinetix, Inc.
CardioKinetix, Inc. Medical SpecialtiesHealth Technology CardioKinetix, Inc. develops ventricular partitioning device for heart failure disease. It develops transcatheter implant called the Parachute Ventricular Partitioning Device, which intends to treat heart failure resulting from a heart attack in patients by improving overall cardiac function. The company was founded by Alexander Khairkhahan, Serjan D. Nikolic and Hugh R. Sharkey in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Hemosphere, Inc.
Hemosphere, Inc. Medical SpecialtiesHealth Technology Hemosphere, Inc. operates as a medical device company. It engages in the development and commercialization of a vascular access device for treating hemodialysis patients with compromised vasculature. The company was founded in 1998 and is headquartered in Eden Prairie, MN. | Health Technology |